Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies

QR Code

Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies

The synthesis of novel indolopyrazoline derivatives (P1-P4 and Q1-Q4) has been characterized and evaluated as potential anti-Alzheimer agents through in vitro Acetylcholinesterase (AChE) inhibition and radical scavenging activity (antioxidant) studies. Specifically, Q3 shows AChE inhibition (IC50: 0...

Full description

Bibliographic Details
Published in:	Bioorganic Chemistry
Main Author:	Chigurupati S.; Selvaraj M.; Mani V.; Selvarajan K.K.; Mohammad J.I.; Kaveti B.; Bera H.; Palanimuthu V.R.; Teh L.K.; Salleh M.Z.
Format:	Article
Language:	English
Published:	Academic Press Inc. 2016
Online Access:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988957420&doi=10.1016%2fj.bioorg.2016.05.002&partnerID=40&md5=888f8a3acf498f30dda9c78f34d76321

Similar Items

Synthesis of azomethines derived from cinnamaldehyde and vanillin: in vitro aetylcholinesterase inhibitory, antioxidant and insilico molecular docking studies
by: Chigurupati S.; Selvaraj M.; Mani V.; Mohammad J.I.; Selvarajan K.K.; Akhtar S.S.; Marikannan M.; Raj S.; Teh L.K.; Salleh M.Z.
Published: (2018)

Synthesis and biological evaluation of indole derivatives as α-amylase inhibitor
by: Imran S.; Taha M.; Selvaraj M.; Ismail N.H.; Chigurupati S.; Mohammad J.I.
Published: (2017)

Synthesis and in vitro study of benzofuran hydrazone derivatives as novel alpha-amylase inhibitor
by: Taha M.; Shah S.A.A.; Imran S.; Afifi M.; Chigurupati S.; Selvaraj M.; Rahim F.; Ullah H.; Zaman K.; Vijayabalan S.
Published: (2017)

LC Method Development and Validation for the Determination of Ropivacaine Hydrochloride in Bulk Drug and Pharmaceutical Formulations
by: Chigurupati S.; Appala R.N.; Selvarajan K.K.; Khaw C.H.; Teoh C.F.; Batumanathan L.; Mohammad J.I.
Published: (2017)

Anticholinesterase activity of octa peptides related to human histatin 8: In-silico drug design and In-vitro
by: Perumal P.; Mani V.; Chigurupati S.; Selvaraj M.
Published: (2017)

New acetylcholinesterase inhibitors isolated from Delphinium uncinatum
by: Gul N.; Ahmad S.; Ahmad H.; Aziz A.; Almehmadi M.; Amer Alsaiari A.; Allahyani M.; Zainab; Adnan Ali Shah S.; Ur Rahman N.; Ahmad M.
Published: (2023)

Synthesis of novel indazole derivatives as inhibitors of diabetics II along with molecular docking and simulation study
by: Al-Nasser F.; Taha M.; Rahim F.; Adalat B.; Chigurupati S.; Nawaz M.; Ajmal A.; Wadood A.; Uddin N.; Khan K.M.; Ali shah S.A.; Felemban S.G.; Venugopal V.
Published: (2025)

In vitro evaluation of acetylcholinesterase inhibitory and neuroprotective activity in commiphora species: A comparative study
by: Dhivya P.S.; Selvamani P.; Latha S.; Mani V.; Azahan N.S.M.
Published: (2020)

Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase
by: Hussain R.; Rahim F.; Rehman W.; Taha M.; Khan S.; Zaman K.; Adnan Ali Shah S.; Wadood A.; Imran S.; Abdellatif M.H.
Published: (2022)

Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease
by: Rahim F.; Javed M.T.; Ullah H.; Wadood A.; Taha M.; Ashraf M.; Qurat-Ul-Ain; Khan M.A.; Khan F.; Mirza S.; Khan K.M.
Published: (2015)

Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study
by: Taha M.; Irshad M.; Imran S.; Chigurupati S.; Selvaraj M.; Rahim F.; Ismail N.H.; Nawaz F.; Khan K.M.
Published: (2017)

Synthesis of novel inhibitors of β-glucuronidase based on the benzothiazole skeleton and their molecular docking studies
by: Taha M.; Ismail N.H.; Imran S.; Selvaraj M.; Rahim F.
Published: (2016)

Synthesis of alpha amylase inhibitors based on privileged indole scaffold
by: Noreen T.; Taha M.; Imran S.; Chigurupati S.; Rahim F.; Selvaraj M.; Ismail N.H.; Mohammad J.I.; Ullah H.; javid M.T.; Nawaz F.; Irshad M.; Ali M.
Published: (2017)

Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation
by: Zha G.-F.; Zhang C.-P.; Qin H.-L.; Jantan I.; Sher M.; Amjad M.W.; Hussain M.A.; Hussain Z.; Bukhari S.N.A.
Published: (2016)

Thiazole based carbohydrazide derivatives as α-amylase inhibitor and their molecular docking study
by: Taha M.; Irshad M.; Imran S.; Rahim F.; Selvaraj M.; Almandil N.B.; Mosaddik A.; Chigurupati S.; Nawaz F.; Ismail N.H.; Ibrahim M.
Published: (2019)

Identification of bisindolylmethane-hydrazone hybrids as novel inhibitors of β-glucuronidase, DFT, and in silico SAR intimations
by: Taha M.; Ismail N.H.; Imran S.; Anouar E.H.; Ali M.; Jamil W.; Uddin N.; Kashif S.M.
Published: (2016)

Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies
by: Taha M.; Ismail N.H.; Imran S.; Selvaraj M.; Rahim A.; Ali M.; Siddiqui S.; Rahim F.; Khan K.M.
Published: (2015)

Identification of novel biomarkers in prostate cancer diagnosis and prognosis
by: Li W.; Xu W.; Sun K.; Wang F.; Wong T.W.; Kong A.-N.
Published: (2022)

In vitro antioxidant and in vivo antidepressant activity of green synthesized azomethine derivatives of cinnamaldehyde
by: Chigurupati S.; Shaikh S.; Mohammad J.; Selvarajan K.; Nemala A.; Khaw C.; Teoh C.; Kee T.
Published: (2017)

Dihydropyrimidones: As novel class of β-glucuronidase inhibitors
by: Ali F.; Khan K.M.; Salar U.; Iqbal S.; Taha M.; Ismail N.H.; Perveen S.; Wadood A.; Ghufran M.; Ali B.
Published: (2016)

Pyrimidine derivatives of n-acetylguanidine: Novel inhibitors of sodium-hydrogen exchanger 1
by: Ozerov A.; Novikov M.; Spasov A.; Iezhitsa I.; Gurova N.; Gurova V.
Published: (2018)

Discovery of polymethoxyflavones as potential cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX) and phosphodiesterase 4B (PDE4B) inhibitors
by: Md Idris M.H.; Mohd Amin S.N.; Mohd Amin S.N.; Wibowo A.; Zakaria Z.A.; Shaameri Z.; Hamzah A.S.; Selvaraj M.; Teh L.K.; Salleh M.Z.
Published: (2022)

New pyrrolopyridine-based thiazolotriazoles as diabetics inhibitors: enzymatic kinetics and in silico study
by: Taha M.; Rahim F.; Hayat S.; Chigurupati S.; Khan K.M.; Imran S.; Ali Shah S.A.; Uddin N.; Felemban S.G.; Venugopal V.
Published: (2023)

Identification of potential mutations associated with multidrug resistance among isolates of Mycobacterium tuberculosis in Malaysia by in silico screening
by: Teh H.W.; Citartan M.; Hamdani H.Y.; Salleh M.Z.; Teh L.K.; Noorizhab M.N.F.B.; Tang T.-H.
Published: (2023)

Synthesis of novel triazinoindole-based thiourea hybrid: A study on α-glucosidase inhibitors and their molecular docking
by: Taha M.; Alshamrani F.J.; Rahim F.; Hayat S.; Ullah H.; Zaman K.; Imran S.; Khan K.M.; Naz F.
Published: (2019)

Mesenchymal Stem Cell-Based Therapies against Podocyte Damage in Diabetic Nephropathy
by: Khalilpourfarshbafi M.; Hajiaghaalipour F.; Selvarajan K.K.; Adam A.
Published: (2017)

Design, synthesis, sar study, antimicrobial and anticancer evaluation of novel 2-mercaptobenzimidazole azomethine derivatives
by: Tahlan S.; Narasimhan B.; Lim S.M.; Ramasamy K.; Mani V.; Shah S.A.A.
Published: (2020)

Design and synthesis of a novel mPGES-1 lead inhibitor guided by 3D-QSAR CoMFA
by: Fasihi Mohd Aluwi M.F.; Rullah K.; Koeberle A.; Werz O.; Abdul Razak N.S.; Wei L.S.; Salim F.; Ismail N.H.; Jantan I.; Wai L.K.
Published: (2019)

Synthesis of novel bisindolylmethanes: New carbonic anhydrase II inhibitors, docking, and 3D pharmacophore studies
by: Imran S.; Taha M.; Ismail N.H.; Fayyaz S.; Khan K.M.; Choudhary M.I.
Published: (2016)

Synthesis, biological evaluation, and docking studies of novel thiourea derivatives of bisindolylmethane as carbonic anhydrase II inhibitor
by: Imran S.; Taha M.; Ismail N.H.; Fayyaz S.; Khan K.M.; Choudhary M.I.
Published: (2015)

Essential Oil Composition of Antidesma cuspidatum and Acetylcholinesterase Inhibitory Activity
by: Ghani N.A.; Salleh W.M.N.H.W.; Salihu A.S.; Rasol N.E.; Khamis S.
Published: (2024)

Chemical Composition and Acetylcholinesterase Inhibitory of the Essential Oil of Boesenbergia curtisii
by: Salleh W.M.N.H.W.; Ghani N.A.; Salihu A.S.; Rasol N.E.; Khamis S.
Published: (2023)

ESSENTIAL OIL COMPOSITION OF Antidesma cuspidatum AND ACETYLCHOLINESTERASE INHIBITORY ACTIVITY
by: Ab Ghani, et al.
Published: (2024)

Acetylcholinesterase Inhibition by Azadirachta Indica Crude Extract on Pomacea Canaliculata
by: Zulkipli N.F.; Hashim S.N.; Rodzali N.N.; Abdullah S.N.A.I.; Muhammad N.A.; Chia-Chay T.; Hassan W.R.M.
Published: (2023)

Synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory potential of hydrazide based Schiff bases
by: Rahim F.; Ullah H.; Taha M.; Wadood A.; Javed M.T.; Rehman W.; Nawaz M.; Ashraf M.; Ali M.; Sajid M.; Ali F.; Khan M.N.; Khan K.M.
Published: (2016)

Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies
by: Taha M.; Ismail N.H.; Lalani S.; Fatmi M.Q.; Atia-Tul-Wahab; Siddiqui S.; Khan K.M.; Imran S.; Choudhary M.I.
Published: (2015)

Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors
by: Taha M.; Imran S.; Rahim F.; Wadood A.; Khan K.M.
Published: (2018)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α-Glucosidase Inhibitor and Their Molecular Docking Studies
by: Inayatsyah, et al.
Published: (2024)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α-Glucosidase Inhibitor and Their Molecular Docking Studies
by: Inayatsyah N.; Ridhwan M.; Aznirulhisham A.; Rasol N.; Kasim N.; Imran S.
Published: (2024)

CHEMICAL COMPOSITION AND ACETYLCHOLINESTERASE ACTIVITY OF Syzygium pyrifolium (Blume) DC. ESSENTIAL OIL
by: Kadir, et al.
Published: (2023)